Get 20% off on all global market reports with code ONLINE20 – stay updated on tariff changes, macroeconomic trends, and more!
Historical Growth of the Polygenic Risk Score Services Market: Insights into Expanding Industry Size
The market size for polygenic risk score services has seen a quick expansion in the recent past. The market, which is expected to expand from $1.24 billion in 2024 to $1.45 billion in 2025, will boast a compound annual growth rate (CAGR) of 16.9%. Several factors have contributed to this growth during the historical period, including a surge in chronic diseases, an increase in personalized medicine demands, growing awareness concerning genetic predispositions, an increase in direct-to-consumer genetic testing availability, and a rise in the implementation of genomic research within the healthcare sector.
The market for polygenic risk score services is predicted to have a significant acceleration in growth in the forthcoming years. It is projected to expand to $2.68 billion by 2029 with a compound annual growth rate (CAGR) of 16.5%. The expected growth in the forecast period can be linked to the increased use of artificial intelligence in genomics, a surge in the demand for preventative health care solutions, heightened investment in genomic research and development, increased integration of genetic data with electronic health records, and a rise in the availability of testing services based on polygenic risk scores. Key trends anticipated in the forecast period involve technological breakthroughs in polygenic risk score algorithms, novelties in multi-omics data amalgamation, progressions in the domain of ancestry-informed polygenic risk scores, exploration and advancement in gene-environment interplays, and progress in applications of pharmacogenomics.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Primary Drivers Are Boosting the Polygenic Risk Score Services Market’s Performance?
The polygenic risk score services market is set to grow due to the increasing focus on personalized medicine. In essence, personalized medicine caters to an individual’s prevention, diagnosis, and treatment according to their unique genetic, environmental, and lifestyle factors. The surge of personalized medicine is stoked by advancements in genomics, which provide a more in-depth understanding of personal genetic variations, leading to more accurate and specific treatment methods.
This consequently enhances patient experiences and minimizes instances of trial-and-error in treatments. By determining multiple genetic variations, Polygenic risk score (PRS) services promote personalized medicine, thereby estimating the likelihood of an individual contracting certain illnesses. This enables healthcare professionals to devise suited prevention tactics, timely interventions, and bespoke treatment plans centered around every patient’s genetic makeup. As per the Personalized Medicine Coalition, an American non-profit organization, as of February 2024, the FDA authorized 16 new individualized treatments in 2023 for patients with rare diseases, showing progress from six in the previous year, 2022. The newly endorsed individualized treatments for 2023 include seven drugs for cancers and three for other diseases and conditions. As such, the increased focus on personalized medicine continues to fuel the polygenic risk score services market’s growth.
Which Key Segments Are Driving Growth in the Polygenic Risk Score Services Market?
The polygenic risk score services market covered in this report is segmented as
1) By Service Type: Genotyping, Sequencing, Data Analysis, Reporting, Other Service Types
2) By Application: Disease Risk Assessment, Personalized Medicine, Research, Other Applications
3) By End-User: Hospitals And Clinics, Research Institutes, Direct-to-Consumer, Other End-Users
Subsegments:
1) By Genotyping: Array-Based Genotyping, Targeted Genotyping, High-Throughput Genotyping
2) By Sequencing: Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Targeted Sequencing
3) By Data Analysis: Polygenic Risk Prediction Algorithms, Bioinformatics And Statistical Analysis, Data Integration With Electronic Health Records (Ehr)
4) By Reporting: Clinical Reports For Healthcare Providers, Direct-To-Consumer (Dtc) Reports, Risk Stratification Reports (Disease-Specific)
5) By Other Service Types: Genetic Counseling Services, Data Storage And Cloud-Based Platforms, Prs Software And Toolkits
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the Key Trends Forecasted to Reshape the Polygenic Risk Score Services Industry Structure?
Major players in the polygenic risk score services industry are prioritizing the creation of groundbreaking solutions such as pharmacogenomics, with a goal of improving personalized treatment plans and boosting patient results. The field of pharmacogenomics is dedicated to understanding how a person’s genetic composition can affect their drug response, ultimately leading to more targeted and individualized treatments. For example, Bupa, a health insurance company based in the UK, introduced a new selection of DNA-based tests in July 2025 to support tailored health and wellness insights. These tests offer bespoke information on drug response and risk of disease, facilitating early detection and customized treatment for ailments like cancer, diabetes, and heart disease. These tests are designed to help avoid adverse reactions, enhance long-term health results, and encourage individuals to take preemptive measures for themselves and their loved ones. The aim is to alter healthcare from a reactive approach to preventive and precise health management.
Which Geographies Are Leading the Expansion of the Polygenic Risk Score Services Market?
North America was the largest region in the polygenic risk score services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polygenic risk score (PRS) services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Polygenic Risk Score Services Market in 2025?
Major companies operating in the polygenic risk score services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Illumina Inc., Endeavor Health Inc., Myriad Genetics Inc., The Broad Institute of MIT and Harvard, BGI Group, Invitae Corporation, 23andMe Holding Co., Color Health Inc., Genomics Ltd., Cogentech S.R.L., Gene by Gene Ltd., Our Future Health Ltd., Mapmygenome India Limited, Australian Genome Research Facility (AGRF) Ltd., Golden Helix Inc., Allelica Inc., Antegenes OÜ, GeninCode Plc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=28302
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
